| Identification | Back Directory | [Name]
2-(4-(5-(3,4-Diethoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylamino)ethanolhydrochloride | [CAS]
1094042-01-9 | [Synonyms]
CS-2567
CYM 5442
CYM 5442 HCl
CYM 5442;CYM-5442
CYM5442 , 1094042-01-9
CYM 5442 hydrochloride
2-(4-(5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylamino)ethanol
Ethanol, 2-[[4-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]-2,3-dihydro-1H-inden-1-yl]amino]-
2-(4-(5-(3,4-Diethoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylamino)ethanolhydrochloride | [Molecular Formula]
C23H27N3O4 | [MDL Number]
MFCD12912402 | [MOL File]
1094042-01-9.mol | [Molecular Weight]
409.48 |
| Chemical Properties | Back Directory | [Boiling point ]
617.5±65.0 °C(Predicted) | [density ]
1.27±0.1 g/cm3(Predicted) | [storage temp. ]
-20°C | [solubility ]
DMSO: >5mg/mL | [form ]
A crystalline solid | [pka]
14.73±0.10(Predicted) | [color ]
Light yellow to light brown | [InChI]
1S/C23H27N3O4/c1-3-28-20-11-8-15(14-21(20)29-4-2)23-25-22(26-30-23)18-7-5-6-17-16(18)9-10-19(17)24-12-13-27/h5-8,11,14,19,24,27H,3-4,9-10,12-13H2,1-2H3 | [InChIKey]
NUIKTBLZSPQGCP-UHFFFAOYSA-N | [SMILES]
CCOc1ccc(cc1OCC)-c2nc(no2)-c3cccc4C(CCc34)NCCO |
| Hazard Information | Back Directory | [Uses]
CYM 5442 is an extracellular lipid mediator whose major effects are mediated by G-protein-coupled receptors. These are important for vascular development. | [Definition]
ChEBI: CYM5442 is an oxadiazole and a ring assembly. | [Biochem/physiol Actions]
CYM-5442 is a highly-selective S1P1 (Spingosine 1-Phosphate Receptor 1) agonist that activates S1P1-dependent pathways in vitro and to levels of full efficacy in vivo through a hydrophobic pocket, separable from the orthosteric site of S1P binding that is headgroup dependent. This is a different site from those involved in the activities of other agonists such as FTY720 and SEW2871. | [in vivo]
CYM5442 (1 mg/kg; intraperitoneal injection; daily; for 5 days; adult male albino Wistar rats) treatment shows preserved visual function of visual evoked potentials (VEP). Retinal nerve fiber layer (RNFL) is significantly thicker in the CYM treated-animals compared to the vehicle[2]. | Animal Model: | Adult male albino Wistar rats (8-10 weeks old; 180-230 g) infected ocular endothelin-1 (ET-1)[2] | | Dosage: | 1 mg/kg | | Administration: | Intraperitoneal injection; daily; for 5 days | | Result: | Visual evoked potentials (VEP) showed preserved visual function. Showed significantly higher retinal ganglion cells (RGCs) numbers.
|
|
|
|